- Home
- ZYME vs SBR Comparison
ZYME vs SBR Comparison
Compare ZYME & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- SBR
- Stock Information
- Founded
- ZYME 2003
- SBR 1982
- Country
- ZYME United States
- SBR United States
- Employees
- ZYME N/A
- SBR N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- SBR Oil & Gas Production
- Sector
- ZYME Health Care
- SBR Energy
- Exchange
- ZYME Nasdaq
- SBR Nasdaq
- Market Cap
- ZYME 968.5M
- SBR 1.1B
- IPO Year
- ZYME 2017
- SBR N/A
- Fundamental
- Price
- ZYME $15.93
- SBR $76.60
- Analyst Decision
- ZYME Buy
- SBR
- Analyst Count
- ZYME 7
- SBR 0
- Target Price
- ZYME $20.00
- SBR N/A
- AVG Volume (30 Days)
- ZYME 446.6K
- SBR 46.5K
- Earning Date
- ZYME 10-30-2025
- SBR 01-01-0001
- Dividend Yield
- ZYME N/A
- SBR 7.14%
- EPS Growth
- ZYME N/A
- SBR N/A
- EPS
- ZYME N/A
- SBR 5.05
- Revenue
- ZYME $122,867,000.00
- SBR $77,682,730.00
- Revenue This Year
- ZYME $107.76
- SBR N/A
- Revenue Next Year
- ZYME $2.35
- SBR N/A
- P/E Ratio
- ZYME N/A
- SBR $15.20
- Revenue Growth
- ZYME 95.94
- SBR N/A
- 52 Week Low
- ZYME $9.03
- SBR $58.25
- 52 Week High
- ZYME $17.70
- SBR $77.49
- Technical
- Relative Strength Index (RSI)
- ZYME 64.90
- SBR 66.23
- Support Level
- ZYME $14.88
- SBR $73.56
- Resistance Level
- ZYME $16.37
- SBR $76.52
- Average True Range (ATR)
- ZYME 0.65
- SBR 1.34
- MACD
- ZYME 0.11
- SBR 0.11
- Stochastic Oscillator
- ZYME 84.12
- SBR 85.62
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About SBR Sabine Royalty Trust
Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.